期刊文献+

CD54、CD80、HLA-DR在Graves病和桥本甲状腺炎甲状腺滤泡上皮中的表达 被引量:4

Expressions of CD54, CD80 and HLA-DR in thyroid epithelial cells from the patients with Graves′ disease and Hashimoto′s thyroiditis
原文传递
导出
摘要 目的观察正常人、Graves病(GD)、桥本甲状腺炎(HT)、甲状腺组织CD54、CD80、HLA-DR的表达。方法免疫组化SP法测定上述各组甲状腺组织CD54、CD80、HLA-DR的表达水平。结果正常甲状腺组织甲状腺滤泡上皮细胞(TEC)几乎不表达CD54和HLA-DR,而GD组和HT组有较高水平的CD54和HLA-DR表达,以HT表达水平最高,3组间比较差异有统计学意义(均P<0.01);HT患者甲状腺CD80表达高于GD组和正常人,差异有统计学意义(均P<0.01),GD组甲状腺CD80表达很低,与正常人相比差异没有统计学意义。结论CD54和HLA-DR在GD和HT的发病机制中起重要作用,CD80在HT的发病中起重要作用。 Objective To observe the expressions of CD54, CD80 and HLA-DR in thyroid epithelial cells (TEC) from normal subjects, patients with Graves' disease (GD) and Hashimoto's thyroiditis (HT) . Methods The expressions of CD54,CD80 and HLA-DR in TEC were assayed by immunohistochemical methods. Results As compared with normal thyroid tissues, the expressions of CD54 and HLA-DR in GD group and HT group were significantly increased ( all P 〈 0.01 ) ; expression of CD80 in HT group was higher than that in normal subjects and GD group ( both P 〈 0. 01 ) , but no different expression of CD80 was found between GD patients and normal subjects. Conclusion Elevated expressions of CD54 and HLA-DR in TEC seem to play an important role in the pathogenesis of GD and HT, while CD80 may contribute to the pathogenesis of HT.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2006年第2期110-113,共4页 Chinese Journal of Endocrinology and Metabolism
基金 重庆卫生局2001-1-15青年人才基金项目
关键词 格雷夫斯病 桥本甲状腺炎 甲状腺 胞间黏附分子1(CD54) 抗原 CD80 HLA-DR抗原 Graves' disease Hashimoto's thyroiditis Thyroid Intercellular adhesion molecule-1(CD54) Antigens, CD80 HLA-DR antigens
  • 相关文献

参考文献13

  • 1Guchi K, Otsubo T, Kawabe Y, et al. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease. Clin Exp Immunol, 1988,72:84-87.
  • 2Pesce G, Fiorino N, Riccio AM. Different intrathyroid expression of intercellular adhesion molecule-1 ( 1CAM-1 ) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with B7.1 costimulatory molecule. J Endocrinol Invest, 2002,25:289-295.
  • 3Marazuela M, Postigo AA, Aceveso A, et al. Adhesion molecules from the LFA-1/ICAM-1, 3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. J Immunol, 1994,24:2483-2490.
  • 4Ozata M, Bolu E, Sengul A. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy Endocr J, 1996,43 :517-525.
  • 5Wakelkamp IM, Gerding MN, van der Meer JW, et al. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy. Clin Exp Immunol, 2002,127:316-320.
  • 6Bonita RE, Rose NR, Rasooly L. Adhesion molecules as susceptibility factors in spontaneous autoimmune thyroiditis in the NOD-H2h4 mouse.Exp Mol Pathol, 2002,73 : 155-163.
  • 7Arreaza G, Yoshikawa N, Mukuta T. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. J Clin Endocrinol Metab, 1995,80:3724-3731.
  • 8Metalfe RA, Tandon N, Tamatani T, et al. Adhesion molecule moneclonal antibody inhibit experimental autoimmune thyroiditis. Immunology, 1993,80:493-497.
  • 9Faure GC, Bensoussan-Lejzerowicz D, Bene MC, et al. Coexpression of CD40 and class Ⅱ antigen HLA-DR in Graves' disease thyroid epithelial cells. Clin Immunol Immunopathol, 1997,84:212-215.
  • 10Flynn JC, Rao PV, Gora M, et al. Graves' hyperthyroidism and thyroiditis in HLA-DRB1 * 0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol, 2004,135:35-40.

同被引文献56

  • 1顾明君,吴文雅,方瑾,李翔,刘春宏,刘志民.甲状腺素及甲状腺内注射地塞米松治疗伴亚临床甲减的桥本甲状腺炎[J].第二军医大学学报,2004,25(9):977-980. 被引量:15
  • 2张琴,付勤,刘鹏鹰,张帆,李永柏,李成荣.CD54、CD40和B7-1分子在桥本甲状腺炎患儿甲状腺组织中的表达[J].临床儿科杂志,2006,24(6):491-493. 被引量:2
  • 3张进安,张健,徐利,买尔哈巴,吴哓燕.自身免疫甲状腺病患者血清中IL-12和IL-18水平的分析[J].细胞与分子免疫学杂志,2006,22(5):630-632. 被引量:13
  • 4Weibin Wen Fengying Liu.Autoantibodies Highly Increased in Patients with Thyroid Dysfunction[J].Cellular & Molecular Immunology,2007,4(3):233-236. 被引量:8
  • 5Lian XL.Bai Y,Sun ML.et al.Clinical validity of anti-thyroperoxidase antibody and anti-thyroplogulin antibody.Zhongguo Yi Xue ke Xue Yuan Xue Bao.2004.26(6):677-81.
  • 6Mysliwiec J.Oklota M,Nikolajuk A,et al.The assessment of usefulness of humoral markers estimation in patients with autoimmune thyroid diseases.Pol Merkuriusz Lek.2005.19(113):663-6.
  • 7Pedro AB,Romaldini JH,Amerieo C,et al.Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves'disease and Hashimoto's thyroiditis patients .Exp Clin Endocrinol.Diabetes.2006.114(1):35-8.
  • 8Zeppa P,Marino G,Lepore M,et al.Flow cytometry phenotypization of thyroidal lymphiod infiltrate and functional status in Hashimoto's thyroiditis.Anal Quant Cytol Histol.2006.28(3):148-56.
  • 9Mazziotti G,Sorvillo F,Naclerio C,et al.Type-1 response in peripheral CD4+and CD8+T cells from patients with Hashimoto's thyroiditis.Eur J Endocrinol.2003.148(4):383-8.
  • 10Okosieme OE.Parkes AB,Premawardhana LD,et al.Peripheral cytokine expression in autoimmune thyroiditis:effects of in vitro modulation by rosiglitazone and dexamethasone.Thyroid.2006.16(10):953-60.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部